Immunological Agents

3. Only agent approved in Entry Inhibitor.
5. New copies of HIV can now infect other cells.
6. HIV enzyme that hides the HIV DNA within the host cell.
10. HIV enzymes that cuts long chain of HIV proteins.
12. Inhibiting the activity of protease.
13. Related to opportunistic pathogens experienced by low percentage of patients in ART.
14. Common side effect of raltegavir.
15. First-choice drug within the NNRTI class.
17. Type of immunity when antigen enters the body w/o human assistance.
18. Prevent viral replication by competing with binding of the reverse transcriptase enzyme.
22. Tuberculosis, bacterial pneumonia, septicemia.
25. Immunity that every person's body make.
26. Drugs hat limits the ability of virus to replicate and infect new cell.

1. Type of infection wherein patients are more vulnerable to infections and malignancies
2. A blueprint to amke long chains of HIV proteins.
4. First-choiceof drug in Protein Inhibitor
7. Necessary for the virus to bind to CD4
8. Cytomegalovirus, herpes simplex, herpes zoster.
9. Vaccinations to tetanus, measles, smallpox etc.
10. Short-term protection against a specific antigen.
11. Drug associated with potentially life-threatening and fatal skin reactions.
16. The standard tretment with HIV infection.
19. Life cycle wherein RNA polymerase creates a copies of HIV genomic material.
20. Wasting of fat.
21. Alternative drug in adult patients during pregnancy.
22. The newly assembled virus pushes out "buds" from the host cell.
23. Cell that the HIV destroys.
24. The most effective and long lasting type of immunity